Marine G. G.
- Country
- France
- Department
- Oncology
Research Overview
- Evaluation of MEDI5752 in Patients with Advanced Solid Tumors: A Clinical Trial
- A Phase 3 Study of MK-2870 Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced or Metastatic Urothelial Carcinoma
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
Data & Insights
Has run more than one trial at 282 of 477 partner sites.
Specializations
Renal Cell Carcinoma Research
Specializes in investigating novel therapeutic approaches for advanced renal cell carcinoma, with particular focus on both clear cell and papillary subtypes. Studies various treatment combinations including immunotherapy and targeted therapies.
- Immune checkpoint inhibitor combinations
- VEGFR-targeted therapies
- Novel therapeutic combinations
Bladder Cancer Expertise
Conducts research across the spectrum of urothelial cancers, from non-muscle invasive to advanced disease states. Investigates innovative treatment approaches including immunotherapy and antibody-drug conjugates.
- Muscle-invasive bladder cancer
- Advanced urothelial carcinoma
- Neoadjuvant therapy approaches
Prostate Cancer Studies
Leads investigations in advanced prostate cancer treatment, particularly focusing on castration-resistant prostate cancer and novel therapeutic approaches including targeted radiotherapy and hormone therapy combinations.
- PSMA-targeted therapies
- Novel hormonal treatments
- Combination therapy approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.